These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 504706)
1. [Results of treatment of advanced cases of non-Hodgkin's-lymphoma (author's transl)]. Kotlarek-Haus S; Nowicka J; Gabryś K; Starzyk H; Becker M; Kaiser A; Hinrle Z Przegl Lek; 1979; 36(7):567-71. PubMed ID: 504706 [No Abstract] [Full Text] [Related]
2. [Present status and future problems in non-Hodgkin's lymphoma. III. On the chemotherapy of non-Hodgkin's lymphoma (author's transl)]. Sakano T Rinsho Ketsueki; 1981 Feb; 22(2):159-77. PubMed ID: 7031290 [No Abstract] [Full Text] [Related]
3. [Comparative study of two drug combination in non-Hodgkin's lymphoma (author's transl)]. Somoza N; Morgenfeld MC; Magnasco J; Pavlovsky S; Cavagnaro FJ; Saslavsky J; de Maria H; Macchi A; Suárez A Sangre (Barc); 1978; 23(4):418-25. PubMed ID: 705564 [No Abstract] [Full Text] [Related]
4. [Combination chemotherapy for advanced diffuse non-Hodgkin's lymphomas in relapse following local radiotherapy]. Sampi K; Honda T; Hattori M Rinsho Hoshasen; 1983 Jun; 28(6):673-7. PubMed ID: 6688641 [No Abstract] [Full Text] [Related]
5. Treatment of recurrent lymphomas with vincristine, BCNU, doxorubicin, and prednisone (VBAP): a Southwest Oncology Group Study. Weick JK; Jones SE; Haut A; Fisher R; Dixon D Cancer Treat Rep; 1981; 65(7-8):611-4. PubMed ID: 6166373 [TBL] [Abstract][Full Text] [Related]
6. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma]. Sampi K; Honda T; Hattori M; Takayama S Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677 [TBL] [Abstract][Full Text] [Related]
7. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis. Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406 [TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase II Study. Miller TP; Jones SE; Rainey JM Cancer Treat Rep; 1983; 67(7-8):739-40. PubMed ID: 6688200 [No Abstract] [Full Text] [Related]
9. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group. Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V; J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of two combination chemotherapies in previously untreated non Hodgkin's lymphoma. Somoza N; Pavlovsky S; Suárez A; Morgenfeld M; Besuschio SC; Bezares R; Quiroga Micheo E; Lein JM; De María H Medicina (B Aires); 1981; 41 Suppl():35-43. PubMed ID: 7345350 [No Abstract] [Full Text] [Related]
11. A comparative study with COP and COP-Bleo combination chemotherapy in advanced (non-Hodgkin's) lymphomas. Kaku K; Inoue M; Fujii S; Ishida Y; Hiroshige Y; Shinohara K; Nakashima K; Matsumoto N; Kaneko T Nihon Ketsueki Gakkai Zasshi; 1983 Jul; 46(4):940-6. PubMed ID: 6195877 [No Abstract] [Full Text] [Related]
13. [Combination chemotherapy in advanced malignant lymphoma with bleomycin, vincristine, adriamycin and prednisolone (author's transl)]. Kurita S; Kamei Y; Murakami M; Oyama A; Goto T; Fukushima M; Ota K Rinsho Ketsueki; 1982 Jan; 23(1):61-7. PubMed ID: 6178855 [No Abstract] [Full Text] [Related]
14. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology. Canellos GP; Skarin AT; Rosenthal DS; Moloney WC; Frei E Cancer Treat Rep; 1981; 65 Suppl 1():125-9. PubMed ID: 6173118 [TBL] [Abstract][Full Text] [Related]
16. [Results of treating lymphomas with high degree of malignancy using COPP, CHOP-Bleo and MEV protocols]. Płuzańska A; Krykowski E; Robak T; Oliskiewicz W; Polkowska E; Dowgier I; Hyjek E Pol Tyg Lek; 1982 Sep; 37(36):1049-53. PubMed ID: 6189105 [No Abstract] [Full Text] [Related]
17. [Chemotherapy of non-Hodgkin lymphoma by the COP schedule]. Krajewska B; Solska E; Dziewulska-Bokiniec A Wiad Lek; 1981 May; 34(10):815-9. PubMed ID: 7293181 [No Abstract] [Full Text] [Related]
18. [Preliminary therapeutic results of treatment of non-Hodgkin lymphoma in children according to the BACOP program]. Bogusławska-Jaworska J; Grześkowiak-Melanowska J; Kaczmarek M; Kościelniak E; Legutko L; Sońta-Jakimczyk D; Sroczyńska M; Wojcik Z Pediatr Pol; 1980 Feb; 55(2):207-10. PubMed ID: 6154919 [No Abstract] [Full Text] [Related]
19. Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin's lymphoma--a 20-year follow-up. Björkholm M; Celsing F; Johansson E; Ann Hematol; 2006 Oct; 85(10):731-3. PubMed ID: 16838163 [No Abstract] [Full Text] [Related]